Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Twist Bioscience (NASDAQ:TWST), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Inhibrx (NASDAQ:INBX).
The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Twist Bioscience (NASDAQ:TWST), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Inhibrx (NASDAQ:INBX).
The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Twist Bioscience (NASDAQ:TWST), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Inhibrx (NASDAQ:INBX).
The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Twist Bioscience (NASDAQ:TWST), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Inhibrx (NASDAQ:INBX).
The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Twist Bioscience (NASDAQ:TWST), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Inhibrx (NASDAQ:INBX).
The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Twist Bioscience (NASDAQ:TWST), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Inhibrx (NASDAQ:INBX).
The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Twist Bioscience (NASDAQ:TWST), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Inhibrx (NASDAQ:INBX).
The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Twist Bioscience (NASDAQ:TWST), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Inhibrx (NASDAQ:INBX).
The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
Day Range17.950 - 18.670 | 52 Wk Range7.100 - 152.560 | Open / Close18.460 / 18.090 | Float / Outstanding64.756M / 68.161M |
Vol / Avg.687.568K / 1.087M | Mkt Cap1.230B | P/E- | 50d Avg. Price16.230 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float64.756M | EPS-11.754 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Twist Bioscience (NASDAQ:TWST), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Inhibrx (NASDAQ:INBX).
The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.